A Co(III) complex
of 1-amino-4-hydroxy-9,10-anthraquinone (QH)
(Scheme-1) having the molecular formula CoQ3 (Scheme-2)
was prepared and characterized by elemental analysis, FTIR spectroscopy,
UV–vis spectroscopy, fluorescence spectroscopy, and mass spectrometry.
In the absence of a single crystal, the energy-optimized molecular
structure of CoQ3 was determined by employing computational
methods that was validated using spectroscopic evidences, elemental
analysis, and mass spectrometry data. The electrochemical properties
of the complex were analyzed using cyclic voltammetry and indicate
a substantial modification of the electrochemical properties of the
parent amino-hydroxy-9,10-anthraquinone. CoQ3 was thereafter
tested on MCF-7 human breast cancer cells. The IC50 value
for a 24 h incubation was found to be (95 ± 0.05) μg/mL.
The study showed that such cancer cells underwent both early and late
apoptosis following the interaction with CoQ3.